Department of Chemistry, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.
Department of Chemistry, The University of Kentucky, Lexington, Kentucky 40506, United States.
Biochemistry. 2024 Jul 2;63(13):1674-1683. doi: 10.1021/acs.biochem.4c00166. Epub 2024 Jun 19.
-Acetylnorloline synthase (LolO) is one of several iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenases that catalyze sequential reactions of different types in the biosynthesis of valuable natural products. LolO hydroxylates C2 of 1--acetamidopyrrolizidine before coupling the C2-bonded oxygen to C7 to form the tricyclic loline core. Each reaction requires cleavage of a C-H bond by an oxoiron(IV) (ferryl) intermediate; however, different carbons are targeted, and the carbon radicals have different fates. Prior studies indicated that the substrate-cofactor disposition (SCD) controls the site of H abstraction and can affect the reaction outcome. These indications led us to determine whether a change in SCD from the first to the second LolO reaction might contribute to the observed reactivity switch. Whereas the single ferryl complex in the C2 hydroxylation reaction was previously shown to have typical Mössbauer parameters, one of two ferryl complexes to accumulate during the oxacyclization reaction has the highest isomer shift seen to date for such a complex and abstracts H from C7 ∼ 20 times faster than does the first ferryl complex in its previously reported off-pathway hydroxylation of C7. The detectable hydroxylation of C7 in competition with cyclization by the ferryl complex is not enhanced in HO solvent, suggesting that the C2 hydroxyl is deprotonated prior to C7-H cleavage. These observations are consistent with the coordination of the C2 oxygen to the ferryl complex, which may reorient its oxo ligand, the substrate, or both to positions more favorable for C7-H cleavage and oxacyclization.
乙酰基诺洛林合酶(LolO)是几种铁(II)和 2-氧代戊二酸依赖性(Fe/2OG)加氧酶之一,它们在有价值的天然产物生物合成中催化不同类型的连续反应。LolO 在将 C2 键合的氧与 C7 偶联形成三环洛林核心之前,将 1--乙酰氨基吡咯里西啶的 C2 羟化。每个反应都需要通过氧代铁(IV)(铁酰基)中间体裂解 C-H 键;然而,不同的碳原子是靶标,自由基有不同的命运。先前的研究表明,底物-辅因子排布(SCD)控制 H 原子的提取位置,并可能影响反应结果。这些迹象表明,从第一个 LolO 反应到第二个 LolO 反应的 SCD 变化是否可能导致观察到的反应性转换。虽然先前已经表明第一个 C2 羟化反应中的单个铁酰基复合物具有典型的穆斯堡尔参数,但在氧杂环化反应中积累的两个铁酰基复合物之一具有迄今为止所见的此类复合物中最高的异核位移,并从 C7 中提取 H 的速度比其先前报道的 C7 非路径羟化中的第一个铁酰基复合物快约 20 倍。在 HO 溶剂中,与环化竞争的可检测到的 C7 羟化没有增强,这表明在 C7-H 裂解之前 C2 羟基被去质子化。这些观察结果与 C2 氧与铁酰基复合物的配位一致,这可能使其氧代配体、底物或两者重新定向到更有利于 C7-H 裂解和氧杂环化的位置。